12 April 2022 in Nature Cell Biology
17 October 2024 in American Journal of Ophthalmology Case Reports
To report a case of neovascular glaucoma in an 8-year-old male, secondary to a racemose hemangioma without associated intracranial arteriovenous malformation, highlighting the challenges in management and novel findings on optical coherence tomography angiography (OCTA). An 8-year-old male initially presented with pain, redness, and blurred vision in the right eye. The patient was diagnosed with secondary neovascular glaucoma due to a racemose hemangioma. Urgent interventions included intravitreal bevacizumab injection and tube shunt surgery for persistently high intraocular pressure. Pars plana vitrectomy and scatter laser photocoagulation were eventually performed to manage a tractional retinal detachment and peripheral ischemia, respectively. OCTA imaging revealed a racemose hemangioma with a unique chorioretinal anastomosis. We present a rare pediatric case of neovascular glaucoma secondary to a racemose hemangioma with significant peripheral ischemia and an unusual chorioretinal anastomosis. The discovery of a chorioretinal anastomosis on OCTA suggests a potentially severe variant of racemose hemangioma.
17 September 2026 in Cell
13 April 2022 in Research Square
CRISPR-Cas nucleases and their nuclease-deactivated dCas variants have revolutionized the field of genome editing and gene regulation. Cas12a possesses intrinsic RNAse activity and can process multiple functional crRNAs from a single long transcript, making it a powerful tool for multiplex gene targeting. We engineered a dCas12a variant termed hyperCas12a with superior efficacy in gene editing and multiplex gene regulation, especially at restrictive crRNA concentrations. Here, we describe a step-by-step protocol for constructing and validating a crRNA array, and using it with the hyperdCas12a system for multiplex gene regulation in vivo by subretinal delivery in mice.
8 March 2023 in American Journal of Ophthalmology Case Reports